Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Tyson Timothy. Officer active across 2 companies, notably Tyme Technologies, INC.. Aggregated, 6 reports have been logged. Split: 1 buy · 0 sell. History available since 16 September 2022. The latest transaction was filed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
TYSON TIMOTHY is a director at Syros Pharmaceuticals, Inc. and Tyme Technologies, INC. He has 6 filings in total, and in the sampled recent filings the period runs from 2022-09-16 to 2024-06-07, with transactions described as Attribution.